Krzysztof Gosik

Medical University of Lublin

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Wojciech Kwasniewski

assistant professor

Gdański Uniwersytet Medyczny

POLAND

View details

Sebastian Mertowski

Medical University of Lublin

POLAND

View details

Agnieszka Rolinska

Medical University of Lublin

POLAND

View details

Jacek Rolinski

Prof

Medical University of Lublin

POLAND

View details

Anna Malm

Head of Department, Professor

Medical University of Lublin

POLAND

View details

Izabela Korona-Glowniak

associate professor/Ph.D.

Medical University of Lublin

POLAND

View details

Violetta Opoka-Winiarska

Professor, Head of the Department of Paediatric Pulmonology and Rheumatology

Medical University of Lublin

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Krzysztof Gosik

Research Interests

Explore related searches

Contact this professor

Articles (9)

Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine

Programmed Cell Death Protein-1 Regulation in Response to SARS-CoV-2 in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2: A Prospective Cohort Study

Proceedings of the 29th European Paediatric Rheumatology Congress

Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?

Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis

TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives

TLR2 Expression on Select Lymphocyte Subsets as a New Marker in Glomerulonephritis

Collaborators (7)

Wojciech Kwasniewski

Sebastian Mertowski

Agnieszka Rolinska

Jacek Rolinski

Anna Malm

Izabela Korona-Glowniak

Violetta Opoka-Winiarska

Make your next move.

Krzysztof Gosik

Research Interests

Explore related searches

Contact this professor

Articles (9)

Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine

Programmed Cell Death Protein-1 Regulation in Response to SARS-CoV-2 in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2: A Prospective Cohort Study

Proceedings of the 29th European Paediatric Rheumatology Congress

Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia&mdash;Any Link with Known Prognostic Factors?

Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis

TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives

TLR2 Expression on Select Lymphocyte Subsets as a New Marker in Glomerulonephritis

Collaborators (7)

Wojciech Kwasniewski

Sebastian Mertowski

Agnieszka Rolinska

Jacek Rolinski

Anna Malm

Izabela Korona-Glowniak

Violetta Opoka-Winiarska

Make your next move.

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?